Ngā hua rapu - Plotnikov, Alexei

Population pharmacokinetics and pharmacodynamics of rivaroxaban in patients with acute coronary syndromes mā Xu, Xu Steven, Moore, Kenneth, Burton, Paul, Stuyckens, Kim, Mueck, Wolfgang, Rossenu, Stefaan, Plotnikov, Alexei, Gibson, Michael, Vermeulen, An

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

HCN212-channel biological pacemakers manifesting ventricular tachyarrhythmias are responsive to treatment with I(f) blockade mā Plotnikov, Alexei N., Bucchi, Annalisa, Shlapakova, Iryna, Danilo, Peter, Brink, Peter R., Robinson, Richard B., Cohen, Ira S., Rosen, Michael R.

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

Safety and Efficacy of Rivaroxaban When Added to Aspirin Monotherapy Among Stabilized Post‐Acute Coronary Syndrome Patients: A Pooled Analysis Study of ATLAS ACS‐TIMI 46 and ATLAS... mā Gibson, William J., Gibson, C. Michael, Yee, Megan K., Korjian, Serge, Daaboul, Yazan, Plotnikov, Alexei N., Burton, Paul, Braunwald, Eugene

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

P2Y12 Inhibitor Switching in Response to Routine Notification of CYP2C19 Clopidogrel Metabolizer Status Following Acute Coronary Syndromes mā Povsic, Thomas J., Ohman, E. Magnus, Roe, Matthew T., White, Jennifer, Rockhold, Frank W., Montalescot, Gilles, Cornel, Jan H., Nicolau, Jose C., Steg, P. Gabriel, James, Stefan, Bode, Christoph, Welsh, Robert C., Plotnikov, Alexei N., Mundl, Hardi, Gibson, C. Michael

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa